Dr. Reddy’s expands collaboration with Gilead Sciences for investigational once-yearly lenacapavir for HIV prevention Read more
Gilead Sciences signs licencing agreements with six companies to manufacture, commercialise Lenacapavir Read more
Dr Reddy’s receives positive CHMP opinion for biosimilar Rituximab candidate in European markets Read more